Dbv Technologies S.A. (DBVT) intrinsic value & 10-year financials

Dbv Technologies S.A. (DBVT) has a Graham intrinsic value of $1.67 per share. At $9.05 on Oct 17, 2026, the stock trades 442% above that value. Over the last 10 fiscal years revenue shrank 5.2% a year to $5.6M, with an average return on invested capital of -4355.3%.

Graham intrinsic value
$1.67
Share price (Oct 17, 2026)
$9.05
Price vs Graham value
442% above
Market cap
$1.3B
Revenue (FY2025)
$5.6M
Revenue growth (10-yr CAGR)
-5.2%
ROIC (10-yr avg)
-4355.3%
Free cash flow (FY2025)
-$121.7M

DBVT 10-year financial history

Fiscal year Revenue Net income EPS (diluted) Free cash flow Operating margin ROIC
FY2025 $5.6M -$146.9M -$1.05 -$121.7M -2609.2% 1567.0%
FY2024 $4.2M -$113.9M -$1.17 -$106.8M -2808.7% -5097.9%
FY2023 $15.7M -$72.7M -$0.76 -$80.3M -486.0% 1488.7%
FY2022 $4.8M -$96.3M -$1.24 -$56.4M -1994.9% -1206.7%
FY2021 $5.7M -$97.8M -$1.78 -$109.2M -1727.6% -388.8%
FY2020 $11.3M -$159.6M — -$168.3M -1408.7% -1435.4%
FY2019 $14.7M -$172.0M — -$153.9M -1162.8% -17034.2%
FY2018 $14.5M -$166.1M — -$141.3M — -21319.1%
FY2017 $11.9M -$147.7M — -$121.6M — -79.2%
FY2016 $9.1M -$114.5M — -$67.5M — -47.2%

Source: annual 10-K filings on SEC EDGAR. Figures in USD.

Executive summary

DBV Technologies S.A. is facing top-line stagnation, with revenue contracting over the decade.

DBV Technologies S.A. has historically struggled to out-earn its cost of capital, averaging just -56.1% ROIC.

DBV Technologies S.A. has not shown aggressive share repurchases (>10% retirement) or a major balance-sheet leverage increase (>50% net debt growth) over the 10-year window.

Benjamin Graham lens

Under Benjamin Graham's formula using SEC EDGAR fundamentals, DBV Technologies S.A. is modeled at -5.2% normalized earnings growth with a 5.1% bond-yield adjustment. The resulting Graham intrinsic value estimate is $1.67 per share.

DBVT stock: frequently asked questions

What is the intrinsic value of Dbv Technologies S.A. (DBVT) stock?

Using Benjamin Graham's revised formula, V = EPS × (8.5 + 2g) × 4.4 / Y, with reported diluted earnings per share, a -5.2% normalized growth rate (capped at 15%) and a 5.1% AAA corporate bond yield, DBVT's intrinsic value is about $1.67 per share.

Is DBVT stock undervalued?

At $9.05 (close on Oct 17, 2026), DBVT trades 442% above its Graham value of $1.67. On Graham's terms the shares look fully priced. A formula is a starting point for research, not a recommendation.

How fast has Dbv Technologies S.A. grown?

Revenue went from $9.1M in fiscal 2016 to $5.6M in fiscal 2025, a compound annual growth rate of -5.2%. Net income was -$146.9M in fiscal 2025.

Does Dbv Technologies S.A. generate free cash flow?

Dbv Technologies S.A. generated -$121.7M of free cash flow (operating cash flow minus capital expenditures) in fiscal 2025. Free cash flow was positive in 0 of the last 10 reported years.

What is DBVT's return on invested capital?

Average ROIC over the last 10 fiscal years was -4355.3%, and average return on equity was -89.3%. Sustained ROIC above about 15% usually points to a durable competitive advantage.

Where does this DBVT data come from?

From Dbv Technologies S.A.'s annual 10-K filings on SEC EDGAR, most recently filed Jul 16, 2026. Prices are end-of-day snapshots; valuations are formula outputs, not investment advice.

Similar biological products stocks